Andrew’s background is in industry, having previously worked with Intel before joining Beats Medical over 7 years ago, leading the commercialisation of the company’s digital therapeutic deployments. Beats Medical delivers digital assessments and therapeutics that transform how central nervous system conditions & rare diseases are managed and understood, to unlock the therapies of the future. With an embedded digital biomarkers approach, Beats Medical facilitate the greater exploration of data from the initial phases of clinical trials, through to long-term real world evidence generation. This unique digital biomarker focus is what fuels Beats Medical’s vision to unlock the healthcare breakthroughs of the future, today. As the Chief Operating Officer, Andrew oversees all commercial activities with a focus on growth and partnerships.